Omeros Stock Fundamentals
| OMER Stock | USD 7.63 0.86 10.13% |
Omeros fundamentals help investors to digest information that contributes to Omeros' financial success or failures. It also enables traders to predict the movement of Omeros Stock. The fundamental analysis module provides a way to measure Omeros' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omeros stock.
At this time, Omeros' Cost Of Revenue is relatively stable compared to the past year. As of 12/15/2024, Non Operating Income Net Other is likely to grow to about 3.8 M, while Interest Expense is likely to drop slightly above 9.7 M. Omeros | Select Account or Indicator |
Omeros Company Return On Equity Analysis
Omeros' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Omeros Return On Equity | -5.76 |
Most of Omeros' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omeros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Omeros Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Omeros has a Return On Equity of -5.7633. This is 75.96% lower than that of the Pharmaceuticals sector and 84.19% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Omeros Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Omeros's current stock value. Our valuation model uses many indicators to compare Omeros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omeros competition to find correlations between indicators driving Omeros's intrinsic value. More Info.Omeros is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Omeros' Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Omeros by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Omeros Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omeros' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omeros could also be used in its relative valuation, which is a method of valuing Omeros by comparing valuation metrics of similar companies.Omeros is currently under evaluation in return on equity category among its peers.
Omeros Current Valuation Drivers
We derive many important indicators used in calculating different scores of Omeros from analyzing Omeros' financial statements. These drivers represent accounts that assess Omeros' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Omeros' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 541.2M | 697.8M | 817.1M | 141.8M | 205.2M | 289.0M | |
| Enterprise Value | 686.8M | 730.5M | 839.1M | 472.8M | 559.6M | 360.6M |
Omeros ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Omeros' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Omeros' managers, analysts, and investors.Environmental | Governance | Social |
Omeros Fundamentals
| Return On Equity | -5.76 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 528.47 M | ||||
| Shares Outstanding | 57.95 M | ||||
| Shares Owned By Insiders | 4.44 % | ||||
| Shares Owned By Institutions | 43.67 % | ||||
| Number Of Shares Shorted | 8.92 M | ||||
| Price To Earning | 0.73 X | ||||
| Price To Book | 8.44 X | ||||
| Price To Sales | 4.93 X | ||||
| Gross Profit | (71.4 M) | ||||
| EBITDA | (163.61 M) | ||||
| Net Income | (117.81 M) | ||||
| Cash And Equivalents | 122.56 M | ||||
| Cash Per Share | 1.95 X | ||||
| Total Debt | 361.58 M | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | (2.66) X | ||||
| Cash Flow From Operations | 74.73 M | ||||
| Short Ratio | 6.15 X | ||||
| Earnings Per Share | (3.14) X | ||||
| Price To Earnings To Growth | (0.17) X | ||||
| Target Price | 43.0 | ||||
| Number Of Employees | 198 | ||||
| Beta | 1.48 | ||||
| Market Capitalization | 442.16 M | ||||
| Total Asset | 378.27 M | ||||
| Retained Earnings | (753.53 M) | ||||
| Working Capital | 306.85 M | ||||
| Current Asset | 37.15 M | ||||
| Current Liabilities | 16.25 M | ||||
| Net Asset | 378.27 M |
About Omeros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omeros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omeros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omeros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -800.1 K | -760.1 K | |
| Cost Of Revenue | 69.8 M | 73.3 M | |
| Stock Based Compensation To Revenue | 0.23 | 0.22 | |
| Sales General And Administrative To Revenue | 1.13 | 1.08 | |
| Research And Ddevelopement To Revenue | 1.73 | 1.64 | |
| Revenue Per Share | 1.16 | 1.22 | |
| Ebit Per Revenue | (1.35) | (1.42) |
Pair Trading with Omeros
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.Moving together with Omeros Stock
Moving against Omeros Stock
| 0.84 | AMGN | Amgen Inc | PairCorr |
| 0.75 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.74 | AVDL | Avadel Pharmaceuticals | PairCorr |
| 0.68 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.66 | TTOO | T2 Biosystms | PairCorr |
The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.
The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Omeros Stock Analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.